Unaudited Consolidated Statement of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenues
Licensed Sales	$ 6,050	$ 2,846	$ 20,003	$ 8,509
Patent licensing fees		575,000	7,049,000	1,196,250
Management fees				24,302
Total revenue	6,050	577,846	7,069,003	1,229,061
Cost of revenue:
Cost of sales	1,095	377	3,689	1,449
Litigation and licensing expenses	32,460	282,621	6,041,560	807,614
Management support services		396	6,609	25,068
Selling, general and administrative expenses	210,177	197,407	751,863	610,278
Total operating expenses	243,732	480,801	6,803,721	1,444,409
Income /(loss) from operations	(237,682)	97,045	265,282	(215,348)
Other Income and (expenses)
Gain (loss) on derivative	(40,000)	(40,000)	(25,000)	40,000
Interest expense	(165,382)	(194,833)	(472,165)	(426,860)
Total Other Income and (expenses)	(205,381)	(234,833)	(497,164)	(386,860)
Net (loss) before income tax	(443,063)	(137,788)	(231,882)	(602,208)
Income tax		(170)	(1,040,125)	(105,410)
Net loss	(443,063)	(137,958)	(1,272,008)	(707,618)
Net income (loss) attributable to non-controlling interest in subsidiaries	485	21	1,511	(1,190)
Net loss attributable to Quest Patent Research Corporation	$ (442,579)	$ (137,937)	$ (1,270,497)	$ (708,808)
Loss per share - basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average shares outstanding - basic and diluted	383,038,334	313,038,334	383,038,334	313,038,334